Our Science

Scientific Platform

Our proprietary ultra-low radio frequency energy (ulRFE®) technology produces a cognate by measuring and recording the oscillating magnetic field produced by molecules in solution. The ulRFE cognate is delivered locally and non-systemically via a medical device. Pre-clinical and clinical studies suggest the ability to specifically regulate metabolic pathways and replicate known mechanisms of action for proven commercial drugs.

Note: EMulate Therapeutics Voyager® ulRFE® system for GBM is an investigational medical device. Limited by United States law to investigational use only.

What Makes our Technology Unique?

Electrostatic Potential of Molecules in Motion


EMulate Therapeutics Spectrum Diagram

How it Works

Every molecule has a unique electrostatic potential. The electrostatic potential is critically important to the chemical properties of a molecule and how a molecule interacts with, and in, a biological system. Our ‘Super Conducting Quantum Interference Device’ (SQUID) based technology measures the unique electrostatic potential of a molecule, as specific Radio Frequency Energy (RFE). This unique and specific RFE is used to induce electron and charge transfer in a defined bioactive target, altering cell dynamics to produce a therapeutic response.